Zobrazeno 1 - 10
of 209
pro vyhledávání: '"Sun, Jin"'
Autor:
Seung Tae Kim, Sun Young Kim, Jeeyun Lee, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Tae Won Kim, Yong Sang Hong, Seok-Byung Lim, Ji Yeon Baek, Jae Hwan Oh, Joong Bae Ahn, Sang Joon Shin, Sae-Won Han, Seong Geun Kim, Seok Yun Kang, Sun Jin Sym, Dae Young Zang, Yeul Hong Kim, In Sil Choi, Jung Hun Kang, Min-Ji Kim, Young Suk Park
Publikováno v:
Journal of Clinical Oncology. 40:3868-3877
PURPOSE The combination of oxaliplatin and fluoropyrimidine for 6 months is one of the standard options for adjuvant therapy for high-risk stage II and III colorectal cancers (CRCs). The optimal duration of oxaliplatin to diminish neurotoxicity witho
Autor:
Hannah M. Thompson, David D. B. Bates, Jennifer Golia Pernicka, Sun Jin Park, Mahra Nourbakhsh, James L. Fuqua, Megan Fiasconaro, Jessica A. Lavery, Iris H. Wei, Emmanouil P. Pappou, J. Joshua Smith, Garrett M. Nash, Martin R. Weiser, Philip B. Paty, Julio Garcia-Aguilar, Maria Widmar
Publikováno v:
Annals of Surgical Oncology.
Autor:
Hannah M. Thompson, David D. B. Bates, Jennifer Golia Pernicka, Sun Jin Park, Mahra Nourbakhsh, James L. Fuqua, Megan Fiasconaro, Jessica A. Lavery, Iris H. Wei, Emmanouil P. Pappou, J. Joshua Smith, Garrett M. Nash, Martin R. Weiser, Philip B. Paty, Julio Garcia-Aguilar, Maria Widmar
Publikováno v:
Annals of Surgical Oncology.
Autor:
Joo-Hwan Park, Ja Hyun Yeo, Young Saing Kim, Inkeun Park, Hee Kyung Ahn, Eun Kyung Cho, Dong Bok Shin, Jun-Young Yang, Hyung-Sik Kim, Woon Kee Lee, Sun Jin Sym
Publikováno v:
American Journal of Clinical Oncology. 45:61-65
Autor:
In Gyu Hwang, Sang-Cheol Lee, Yaewon Yang, Sung Yong Oh, Sang-Gon Park, So Yeon Jeon, Dae Young Zang, Jung Hun Kang, Jun Ho Ji, Hyun Woo Lee, Woo Kyun Bae, Sun Jin Sym, Se-Il Go, Joung Soon Jang, Jung Hoon Kim
Publikováno v:
European Journal of Cancer. 157:21-30
Background The efficacy of modified FOLFIRINOX (mFOLFIRINOX) as a second-line chemotherapy treatment for metastatic pancreatic adenocarcinoma (mPAC), remains unclear. This multi-center randomised phase III trial aimed to elucidate the efficacy of mFO
Publikováno v:
European Journal of Surgical Oncology. 49:e113
A New Treatment Landscape for RCC: Association of the Human Microbiome with Improved Outcomes in RCC
Autor:
Xuan-Mei Piao, Young Joon Byun, Chuang-Ming Zheng, Sun Jin Song, Ho Won Kang, Won Tae Kim, Seok Joong Yun
Publikováno v:
Cancers. 15:935
Microbes play different roles in metabolism, local or systemic inflammation, and immunity, and the human microbiome in tumor microenvironment (TME) is important for modulating the response to immunotherapy in cancer patients. Renal cell carcinoma (RC
Autor:
Keun-Wook Lee, Markus H. Moehler, David Cunningham, Zev A. Wainberg, Hope Elizabeth Uronis, Do-Youn Oh, In-Ho Kim, Byoung Yong Shim, Sun Jin Sym, Rachel A Altura, Melissa C Stilian, Elizabeth C Parker, Samuel J Klempner
Publikováno v:
Journal of Clinical Oncology. 41:TPS484-TPS484
TPS484 Background: Advanced G/GEJ cancer is a major cause of cancer-related mortality requiring novel therapies. DKN-01 is a humanized mAb that binds and neutralizes DKK1. DKK1 plays a major role in WNT-pathway regulation and is overexpressed in mult
Autor:
Philip J. Gold, Jan K Davidson-Moncada, Keun-Wook Lee, Yeul Hong Kim, Jon M. Wigginton, Minori Koshiji Rosales, Se Hoon Park, Rosalyn A. Juergens, Haeseong Park, Hope E. Uronis, Cheng Ean Chee, Yee Chao, Daniel V.T. Catenacci, Aleksandra Franovic, Yoon-Koo Kang, Jeffrey L. Nordstrom, Kristen A. Marrone, Eun-Kee Song, Jill Lacy, Sunnie Kim, Johanna C. Bendell, Sang Cheul Oh, Matthew C.H. Ng, Ronan J. Kelly, Jennifer Yen, Jong Gwang Kim, Keith L. Knutson, Yung-Jue Bang, A. Craig Lockhart, Howard S. Hochster, Daner Li, Thierry Alcindor, Sun Jin Sym, Peter C. Enzinger
Publikováno v:
The Lancet Oncology. 21:1066-1076
Summary Background Margetuximab, a novel, investigational, Fc-engineered, anti-HER2 monoclonal antibody, is designed to more effectively potentiate innate immunity than trastuzumab. We aimed to evaluate the safety, tolerability, and antitumour activi
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
PurposeWe report nationwide data on the current status of laparoscopic surgery for colorectal cancer (CRC) in Korea.Materials and MethodsNationwide data of patients who underwent surgery for CRC from 2013 to 2018 were obtained from the Health Insuran